61 related articles for article (PubMed ID: 8770857)
21. Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.
Kim DS; Burt AA; Ranchalis JE; Richter RJ; Marshall JK; Eintracht JF; Rosenthal EA; Furlong CE; Jarvik GP
J Lipids; 2012; 2012():476316. PubMed ID: 22685667
[TBL] [Abstract][Full Text] [Related]
22. Synergism between paraoxonase Arg 192 and the angiotensin converting enzyme D allele is associated with severity of coronary artery disease.
Vaisi-Raygani A; Rahimi Z; Tavilani H; Vaisi-Raygani H; Kiani A; Aminian M; Shakiba E; Shakiba Y; Pourmotabbed T
Mol Biol Rep; 2012 Mar; 39(3):2723-31. PubMed ID: 21681430
[TBL] [Abstract][Full Text] [Related]
23. Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis.
Gupta N; Singh S; Maturu VN; Sharma YP; Gill KD
PLoS One; 2011; 6(5):e17805. PubMed ID: 21629682
[TBL] [Abstract][Full Text] [Related]
24. Paraoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy males.
Lüersen K; Schmelzer C; Boesch-Saadatmandi C; Kohl C; Rimbach G; Döring F
BMC Res Notes; 2011 May; 4():141. PubMed ID: 21569287
[TBL] [Abstract][Full Text] [Related]
25. Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease.
Vaisi-Raygani A; Ghaneialvar H; Rahimi Z; Tavilani H; Pourmotabbed T; Shakiba E; Vaisi-Raygani A; Kiani A; Aminian M; Alibakhshi R; Bartels C
Mol Biol Rep; 2011 Nov; 38(8):5421-8. PubMed ID: 21465165
[TBL] [Abstract][Full Text] [Related]
26. Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis.
Banerjee I
Eur J Epidemiol; 2010 Jul; 25(7):449-58. PubMed ID: 20532959
[TBL] [Abstract][Full Text] [Related]
27. Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.
Paragh G; Seres I; Harangi M; Erdei A; Audikovszky M; Debreczeni L; Kovácsay A; Illyés L; Pados G
Br J Clin Pharmacol; 2006 Jun; 61(6):694-701. PubMed ID: 16722831
[TBL] [Abstract][Full Text] [Related]
28. Paraoxonase 1-192Q allele is a risk factor for idiopathic chronic pancreatitis.
Verlaan M; Harbers EG; Pap A; Jansen JB; Peters WH; Drenth JP
Mol Diagn; 2005; 9(1):9-15. PubMed ID: 16035730
[TBL] [Abstract][Full Text] [Related]
29. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis.
Lawlor DA; Day IN; Gaunt TR; Hinks LJ; Briggs PJ; Kiessling M; Timpson N; Smith GD; Ebrahim S
BMC Genet; 2004 Jun; 5():17. PubMed ID: 15214960
[TBL] [Abstract][Full Text] [Related]
30. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
Deakin S; Leviev I; Brulhart-Meynet MC; James RW
Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
[TBL] [Abstract][Full Text] [Related]
31. Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.
Tang Z; Tracy RP
J Thromb Thrombolysis; 2001 Feb; 11(1):49-81. PubMed ID: 11248790
[No Abstract] [Full Text] [Related]
32. [Possible genetic causes for late complications of diabetes mellitus].
Klemm T; Paschke R
Med Klin (Munich); 2000 Jan; 95(1):31-9. PubMed ID: 10668342
[TBL] [Abstract][Full Text] [Related]
33. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.
Sanghera DK; Aston CE; Saha N; Kamboh MI
Am J Hum Genet; 1998 Jan; 62(1):36-44. PubMed ID: 9443862
[TBL] [Abstract][Full Text] [Related]
34. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
[TBL] [Abstract][Full Text] [Related]
35. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
37. Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?
Heinecke JW; Lusis AJ
Am J Hum Genet; 1998 Jan; 62(1):20-4. PubMed ID: 9443884
[No Abstract] [Full Text] [Related]
38. The paraoxonase gene family and coronary heart disease.
Mackness B; Durrington PN; Mackness MI
Curr Opin Lipidol; 2002 Aug; 13(4):357-62. PubMed ID: 12151850
[TBL] [Abstract][Full Text] [Related]
39. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.
Antikainen M; Murtomäki S; Syvänne M; Pahlman R; Tahvanainen E; Jauhiainen M; Frick MH; Ehnholm C
J Clin Invest; 1996 Aug; 98(4):883-5. PubMed ID: 8770857
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
